IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Cancer
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
Seagen Inc.
National Institutes of Health Clinical Center (CC)
BeOne Medicines
AstraZeneca
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Bayer
Roswell Park Cancer Institute
Zymeworks BC Inc.
National Cancer Institute (NCI)
Nammi Therapeutics Inc
OncoC4, Inc.
Compass Therapeutics
National Institutes of Health Clinical Center (CC)
Alnylam Pharmaceuticals
University of Hawaii
Sotio Biotech Inc.
Aptamer Sciences, Inc.